【结 构 式】 |
【药物名称】Nitidine chloride, NSC-146397(anhydrous) 【化学名称】2,3-Dimethoxy-12-methyl[1,3]benzodioxo[5,6-c]phenanthridinium chloride dihydrate 【CA登记号】13063-04-2 (anhydrous), 6872-57-7 (free base, anhydrous) 【 分 子 式 】C21H22ClNO6 【 分 子 量 】419.86559 |
【开发单位】Guangxi Inst. Med. Pharm. Sci., Nanning (Originator) 【药理作用】ONCOLYTIC DRUGS |
合成路线1
The synthesis of nitidine chloride was first reported in 1973. The procedure was based on the synthesis of dihydronitidine, which involves hydrocyanation of the corresponding chalcone, followed by hydrolysis, reduction and cyclization to the 2-aryl tetralone. Leukart reaction of the tetralone followed by ring closure with phosphorus oxychloride and catalytic dehydrogenation yields the benzo[c]phenanthridine nucleus. Methylation and quarternization with methyl sulfate followed by anion exchange with sodium chloride forms the chloride salt of the desired compound. Several other syntheses of nitidine chloride have also been reported. These include: a) synthesis of the intermediates by a different route; b) photocyclization of bromobenzamide from 5-aminonaphthalene to phenanthridine; and c) condensation of homophthalic anhydride and the Schiff base to form the 3-arylisoquinoline. Many analogues of nitidine chloride, including fagaronine. The tetramethoxy analogue, the indenoisoquinoline derivative, etc., possess significant antineoplastic activity.
【1】 Miyadera, T.; et al.; J Heterocycl Chem 1973, 10, 6, 85-88. |
【2】 Pabbathi, V.K.; et al.; J Heterocycl Chem 1973, 10, 2, 31-33. |
【3】 Okamoto, T.; et al.; Tetrahedron Lett 1974, 297, 2, 2269-2270. |
【4】 Muramatsu, I.; Ahmed, M.; Ohnuki, T.; Nagatomo, T.; Futabayashi, Y.; Ishiguro, M.; J Heterocycl Chem 1981, 18, 21, 223-232. |
【5】 Gupta, Y.K.; Sharma, M.; J Org Chem 1978, 43, 21, 286-288. |
【6】 May, H.-J.; J Chem Soc 1959, 30, 10, 4010-4012. |
【7】 Caldwell, J.; Glowka, F.K.; J Chem Soc - Perkins Trans I 1977, 14, 9, 2324-2328. |
【8】 Cheng, C.C.; Zee-Chenh, R.K.-Y.; Preparation and antileukemic activity of some alkoxybenzo[c]phenanthridinium salts and corresponding dihydro derivatives. J Med Chem 1975, 18, 1, 66-71. |
【9】 Cushman, M.; Mohan, P.; Smith, E.C.R.; Synthesis and biological activity of structural analogues of the anticancer benzophenanthridine alkaloid nitidine chloride. J Med Chem 1984, 27, 4, 544-547. |
【10】 Zee-Cheng, R.K.-Y.; Cheng, C.C.; Nitidine Chloride. Drugs Fut 1985, 10, 2, 124. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 18304 | 3,4-Dimethoxybenzaldehyde; Veratraldehyde | 120-14-9 | C9H10O3 | 详情 | 详情 |
(II) | 28953 | 1-(1,3-benzodioxol-5-yl)-1-ethanone | 3162-29-6 | C9H8O3 | 详情 | 详情 |
(III) | 28954 | (E)-1-(1,3-benzodioxol-5-yl)-3-(3,4-dimethoxyphenyl)-2-propen-1-one | C18H16O5 | 详情 | 详情 | |
(IV) | 28955 | 4-(1,3-benzodioxol-5-yl)-2-(3,4-dimethoxyphenyl)-4-oxobutanenitrile | C19H17NO5 | 详情 | 详情 | |
(V) | 28956 | 4-(1,3-benzodioxol-5-yl)-2-(3,4-dimethoxyphenyl)-4-oxobutyric acid | C19H18O7 | 详情 | 详情 | |
(VI) | 28957 | 4-(1,3-benzodioxol-5-yl)-2-(3,4-dimethoxyphenyl)butyric acid | C19H20O6 | 详情 | 详情 | |
(VII) | 28958 | 6-(3,4-dimethoxyphenyl)-7,8-dihydronaphtho[2,3-d][1,3]dioxol-5(6H)-one | C19H18O5 | 详情 | 详情 | |
(VIII) | 28959 | 6-(3,4-dimethoxyphenyl)-5,6,7,8-tetrahydronaphtho[2,3-d][1,3]dioxol-5-ylformamide | C20H21NO5 | 详情 | 详情 | |
(IX) | 28960 | 2,3-dimethoxy-4b,5,6,11b-tetrahydro[1,3]benzodioxolo[5,6-c]phenanthridine | C20H19NO4 | 详情 | 详情 | |
(X) | 28961 | 2,3-dimethoxy[1,3]benzodioxolo[5,6-c]phenanthridine | C20H15NO4 | 详情 | 详情 | |
(XI) | 28962 | 2,3-dimethoxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium (sulfonatooxy)methane | C22H21NO8S | 详情 | 详情 |